Skip to content

Application of Fospropofol Disodium in goal-directed sedation in critically ill patients

Application of Fospropofol Disodium in goal-directed sedation in critically ill patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087605
Enrollment
Unknown
Registered
2024-07-31
Start date
2024-08-10
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, restlessness

Interventions

Group FP:Fospropofol Disodium 3.5mg/kg/h continuous intravenous pump
Group P:Propofol 1.0~4.0 mg/kg/h continuous intravenous pump
Group M:Midazolam 0.02~0.1mg/kg/h continuous intravenous pump.

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Aged =18 years and =80 years old, regardless of gender; ? Patients who need analgesia and sedation when admitted to ICU; ? Mechanical ventilation is expected to be performed for > 24 hours; ? Obtain informed consent from patients or family members.

Exclusion criteria

Exclusion criteria: ? Pregnant or lactating women; ? Allergy to trial drugs or contraindications to the use of opioids; ? Patients with severe craniocerebral injury, brain tumors, increased intracranial pressure, etc. who are prone to respiratory depression; ? Severe, existing substantial liver disease With clinically significant portal hypertension, Child-Pugh class C cirrhosis or acute liver failure; ? Intestinal obstruction at risk (those who have or are at risk of progressing to gastrointestinal obstruction, especially patients with paralytic ileus); ? Hearing or Loss of vision, or any other condition that may seriously interfere with the collection of research data; ? Patients with mental or neurological diseases, cognitive and consciousness disorders, and unable to express correctly; ? Have participated in this research or participated in any other research at the same time; ? Unable to obtain informed consent or authorization.

Design outcomes

Secondary

MeasureTime frame
Delirium incidence;nausea and vomiting incidence;

Primary

MeasureTime frame
Time to achieve sedation goal;Mechanical ventilation time, extubation time, ICU stay time;

Countries

China

Contacts

Public ContactFang Feng

Lanzhou University Second Hospital

ldyy_fengf@lzu.edu.cn+86 138 9332 1205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026